LIVZON PHARMA Schedules 23 April 2026 Board Meeting to Approve Q1 Results

Bulletin Express

Apr 08

Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that its Board of Directors will convene on 23 April 2026 to review and approve the unaudited consolidated results for the three months ended 31 March 2026. Additional routine corporate matters may also be addressed during the session.

The notification, released from Zhuhai on 8 April 2026, lists the current Board composition: • Executive Director: Tang Yanggang (Vice Chairman) • Non-Executive Directors: Zhu Baoguo (Chairman), Lin Nanqi, Qiu Qingfeng • Employee Representative Director: Ran Yongmei • Independent Non-Executive Directors: Bai Hua, Luo Huiyuan, Cui Lijie, Wang Zhiyao

Investors and stakeholders can expect the company to release its first-quarter 2026 financial figures following the Board’s deliberations on the scheduled date.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1182294159"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1182294159\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1182294159?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-08 17:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182294159","market":"hk","top_or_hot":-1,"title":"LIVZON PHARMA Schedules 23 April 2026 Board Meeting to Approve Q1 Results","media":"Bulletin Express","content":"<p>Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that its Board of Directors will convene on 23 April 2026 to review and approve the unaudited consolidated results for the three months ended 31 March 2026. Additional routine corporate matters may also be addressed during the session.</p>\n<p>The notification, released from Zhuhai on 8 April 2026, lists the current Board composition:\n• Executive Director: Tang Yanggang (Vice Chairman)  \n• Non-Executive Directors: Zhu Baoguo (Chairman), Lin Nanqi, Qiu Qingfeng  \n• Employee Representative Director: Ran Yongmei  \n• Independent Non-Executive Directors: Bai Hua, Luo Huiyuan, Cui Lijie, Wang Zhiyao</p>\n<p>Investors and stakeholders can expect the company to release its first-quarter 2026 financial figures following the Board’s deliberations on the scheduled date.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LIVZON PHARMA Schedules 23 April 2026 Board Meeting to Approve Q1 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLIVZON PHARMA Schedules 23 April 2026 Board Meeting to Approve Q1 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-08 17:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that its Board of Directors will convene on 23 April 2026 to review and approve the unaudited consolidated results for the three months ended 31 March 2026. Additional routine corporate matters may also be addressed during the session.</p>\n<p>The notification, released from Zhuhai on 8 April 2026, lists the current Board composition:\n• Executive Director: Tang Yanggang (Vice Chairman)  \n• Non-Executive Directors: Zhu Baoguo (Chairman), Lin Nanqi, Qiu Qingfeng  \n• Employee Representative Director: Ran Yongmei  \n• Independent Non-Executive Directors: Bai Hua, Luo Huiyuan, Cui Lijie, Wang Zhiyao</p>\n<p>Investors and stakeholders can expect the company to release its first-quarter 2026 financial figures following the Board’s deliberations on the scheduled date.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"丽珠医药","start_time":0,"source_url":"","article_id":"1182294159","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182294159","pubTimestamp":1775638900,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that its Board of Directors will convene on 23 April 2026 to review and approve the unaudited consolidated results for the three months...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药定于2026年4月23日召开董事会批准第一季度业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) announced that its Board of Directors will convene on 23 April 2026 to review and approve the unaudited consolidated results for the three months ended 31 March 2026. Additional routine corporate matters may also be addressed during the session.\nThe notification, released from Zhuhai on 8 April 2026, lists the current Board composition:\n• Executive Director: Tang Yanggang (Vice Chairman)  \n• Non-Executive Directors: Zhu Baoguo (Chairman), Lin Nanqi, Qiu Qingfeng  \n• Employee Representative Director: Ran Yongmei  \n• Independent Non-Executive Directors: Bai Hua, Luo Huiyuan, Cui Lijie, Wang Zhiyao\nInvestors and stakeholders can expect the company to release its first-quarter 2026 financial figures following the Board’s deliberations on the scheduled date.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}